Advances in the regulatory mechanisms of mTOR in necroptosis

The mammalian target of rapamycin (mTOR), an evolutionarily highly conserved serine/threonine protein kinase, plays a prominent role in controlling gene expression, metabolism, and cell death. Programmed cell death (PCD) is indispensable for maintaining homeostasis by removing senescent, defective,...

Full description

Bibliographic Details
Main Authors: Yawen Xie, Guoyu Zhao, Xianli Lei, Na Cui, Hao Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1297408/full
_version_ 1797387758110507008
author Yawen Xie
Guoyu Zhao
Xianli Lei
Na Cui
Hao Wang
author_facet Yawen Xie
Guoyu Zhao
Xianli Lei
Na Cui
Hao Wang
author_sort Yawen Xie
collection DOAJ
description The mammalian target of rapamycin (mTOR), an evolutionarily highly conserved serine/threonine protein kinase, plays a prominent role in controlling gene expression, metabolism, and cell death. Programmed cell death (PCD) is indispensable for maintaining homeostasis by removing senescent, defective, or malignant cells. Necroptosis, a type of PCD, relies on the interplay between receptor-interacting serine-threonine kinases (RIPKs) and the membrane perforation by mixed lineage kinase domain-like protein (MLKL), which is distinguished from apoptosis. With the development of necroptosis-regulating mechanisms, the importance of mTOR in the complex network of intersecting signaling pathways that govern the process has become more evident. mTOR is directly responsible for the regulation of RIPKs. Autophagy is an indirect mechanism by which mTOR regulates the removal and interaction of RIPKs. Another necroptosis trigger is reactive oxygen species (ROS) produced by oxidative stress; mTOR regulates necroptosis by exploiting ROS. Considering the intricacy of the signal network, it is reasonable to assume that mTOR exerts a bifacial effect on necroptosis. However, additional research is necessary to elucidate the underlying mechanisms. In this review, we summarized the mechanisms underlying mTOR activation and necroptosis and highlighted the signaling pathway through which mTOR regulates necroptosis. The development of therapeutic targets for various diseases has been greatly advanced by the expanding knowledge of how mTOR regulates necroptosis.
first_indexed 2024-03-08T22:29:44Z
format Article
id doaj.art-c768554c862d45c9b021c267ceeda529
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-08T22:29:44Z
publishDate 2023-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-c768554c862d45c9b021c267ceeda5292023-12-18T06:55:20ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-12-011410.3389/fimmu.2023.12974081297408Advances in the regulatory mechanisms of mTOR in necroptosisYawen Xie0Guoyu Zhao1Xianli Lei2Na Cui3Hao Wang4Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, ChinaDepartment of Critical Care Medicine, Beijing Jishuitan Hospital, Capital Medical University, Beijing, ChinaThe mammalian target of rapamycin (mTOR), an evolutionarily highly conserved serine/threonine protein kinase, plays a prominent role in controlling gene expression, metabolism, and cell death. Programmed cell death (PCD) is indispensable for maintaining homeostasis by removing senescent, defective, or malignant cells. Necroptosis, a type of PCD, relies on the interplay between receptor-interacting serine-threonine kinases (RIPKs) and the membrane perforation by mixed lineage kinase domain-like protein (MLKL), which is distinguished from apoptosis. With the development of necroptosis-regulating mechanisms, the importance of mTOR in the complex network of intersecting signaling pathways that govern the process has become more evident. mTOR is directly responsible for the regulation of RIPKs. Autophagy is an indirect mechanism by which mTOR regulates the removal and interaction of RIPKs. Another necroptosis trigger is reactive oxygen species (ROS) produced by oxidative stress; mTOR regulates necroptosis by exploiting ROS. Considering the intricacy of the signal network, it is reasonable to assume that mTOR exerts a bifacial effect on necroptosis. However, additional research is necessary to elucidate the underlying mechanisms. In this review, we summarized the mechanisms underlying mTOR activation and necroptosis and highlighted the signaling pathway through which mTOR regulates necroptosis. The development of therapeutic targets for various diseases has been greatly advanced by the expanding knowledge of how mTOR regulates necroptosis.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1297408/fullmTORnecroptosisautophagyRIPKROS
spellingShingle Yawen Xie
Guoyu Zhao
Xianli Lei
Na Cui
Hao Wang
Advances in the regulatory mechanisms of mTOR in necroptosis
Frontiers in Immunology
mTOR
necroptosis
autophagy
RIPK
ROS
title Advances in the regulatory mechanisms of mTOR in necroptosis
title_full Advances in the regulatory mechanisms of mTOR in necroptosis
title_fullStr Advances in the regulatory mechanisms of mTOR in necroptosis
title_full_unstemmed Advances in the regulatory mechanisms of mTOR in necroptosis
title_short Advances in the regulatory mechanisms of mTOR in necroptosis
title_sort advances in the regulatory mechanisms of mtor in necroptosis
topic mTOR
necroptosis
autophagy
RIPK
ROS
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1297408/full
work_keys_str_mv AT yawenxie advancesintheregulatorymechanismsofmtorinnecroptosis
AT guoyuzhao advancesintheregulatorymechanismsofmtorinnecroptosis
AT xianlilei advancesintheregulatorymechanismsofmtorinnecroptosis
AT nacui advancesintheregulatorymechanismsofmtorinnecroptosis
AT haowang advancesintheregulatorymechanismsofmtorinnecroptosis